Below are some of the most frequently asked questions about China Biologic.  If you don't find what you're looking for here, please contact us directly.

What is China Biologic Products' core business?

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in China. Plasma products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. The Company’s plasma products are sold to hospitals, distributors and other healthcare facilities in China.

What is the address of China Biologic Products' headquarter?

Room 1801, Jialong International Tower
No.19 Chaoyang Park Road, Chaoyang District
Beijing, 100125, China

How many employees does China Biologic Products have?

China Biologic had 1,912 full-time employees as of December 31, 2017.

What is China Biologic Products' fiscal year and corresponding quarter-end dates?

We operate on a calendar year, which runs from January 1 - December 31. Quarter-ends are: March 31, June 30, September 30 and December 31.

What is China Biologic Products' ticker symbol, exchange and CUSIP?

China Biologic Products listed on the NASDAQ Global Market in the United States under symbol “CBPO”, and our CUSIP number is 16938C106.

How can I get a copy of the annual report?

Annual reports are available via this website. To request a hardcopy, please contact our Investor Relations Department via

Who is China Biologic Products' Independent Chartered Public Accountant?

Our Independent Chartered Public Accountant is KPMG.

Who is China Biologic Products' outside legal counsel?

Wilson Sonsini Goodrich & Rosati P.C.
Unit 1001, 10/F Henley Bldg
5 Queen's Road Central, Hong Kong
Phone: +852 3972 4955

Who is China Biologic Products' transfer agent and registrar?

Securities Transfer Corporation.
2591 Dallas Parkway, Suite #102, Frisco, Texas, 75034
Phone: +1-469 633 0101

How can I contact China Biologic Products' Investor Relations Department?

CBPO Investor Relations

The Foote Group
Philip Lisio
Tel: +86-135-0116-6560